Alfonso Thaddeus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alfonso Thaddeus has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- D. M. Christe
Formerly at Regional Centre for Clinical Research in Human Reproduction, Govt. Hospital for Women and Children, Institute of Obstetrics and Gynecology] Department of Clinical Research, NIRT-ICMR [Indian Council of Medical Research], Chetpet, Chennai, India
1 shared publication - G. Thiripurasundari
Department of Obstetrics and Gynecology, Govt. Hospital for Women and Children, Institute of Obstetrics and Gynecology, Madras Medical College, Chennai, India
1 shared publication - Geetha Muttath
Department of Radiation Oncology Malabar Cancer Centre Thalassery Kerala India
1 shared publication - Jaya Prasad Tripathy
Department of Community Medicine All India Institute of Medical Sciences Nagpur India
1 shared publication - Kalpita Shringarpure
Sir Sayajirao General Hospital Medical College
1 shared publication - Karthickeyan Duraisamy
Academy for Public Health, Kozhikode, India
1 shared publication
Latest Publications
- 4 October 2021
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 19 (4) , 1-6
Efficacy of VIA, VILI, PAP Smear, and FRD Tests in Screening for Cervical Cancer: A Comparative Study
- 4 October 2021
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 19 (4) , 1-6
Efficacy of VIA, VILI, PAP Smear, and FRD Tests in Screening for Cervical Cancer: A Comparative Study
- Open Access
- 11 January 2019
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 17 (1) , 1-7
Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India
Oral cancer is very common in India. The reported 5-year survival of such patients is around 50% after treatment with surgery and radiotherapy, much lower than most of the developed countries. A retrospective study of a prospective database of oral cancer patients undergoing surgery from June 2009 to June 2013 was conducted. Follow-up details were updated from case records and by phone calls. Data were double entered in EpiData Entry version 3.1 and were analysed using EpiData Analysis software 2.1.0.73. Two-hundred and twenty patients were analysed (136 males); 85% were consuming tobacco, mainly in chewable form. The majority (51.1%) had tongue cancer, of whom 75 patients (34.1%) had T4 tumours. Postoperative radiotherapy was given to 108 patients (49.1%). Forty had recurrence, of which 23 were in early stage. Of these, 19 showed node positivity (p < 0.01). Node-negative patients had 79% 5-year survival while node positive had 59% which is comparable to that reported in developed countries. Median disease-free survival duration was 48.2 months. Node positivity is the single factor affecting recurrence and survival. The overall survival and disease-free survival is better in patients without lymph node involvement and in patients with early stage of cancer as compared to the patients with node involvement and in advanced stages.
- 11 January 2019
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 17 (1) , 1-7
Open AccessImproved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India
Oral cancer is very common in India. The reported 5-year survival of such patients is around 50% after treatment with surgery and radiotherapy, much lower than most of the developed countries. A retrospective study of a prospective database of oral cancer patients undergoing surgery from June 2009 to June 2013 was conducted. Follow-up details were updated from case records and by phone calls. Data were double entered in EpiData Entry version 3.1 and were analysed using EpiData Analysis software 2.1.0.73. Two-hundred and twenty patients were analysed (136 males); 85% were consuming tobacco, mainly in chewable form. The majority (51.1%) had tongue cancer, of whom 75 patients (34.1%) had T4 tumours. Postoperative radiotherapy was given to 108 patients (49.1%). Forty had recurrence, of which 23 were in early stage. Of these, 19 showed node positivity (p < 0.01). Node-negative patients had 79% 5-year survival while node positive had 59% which is comparable to that reported in developed countries. Median disease-free survival duration was 48.2 months. Node positivity is the single factor affecting recurrence and survival. The overall survival and disease-free survival is better in patients without lymph node involvement and in patients with early stage of cancer as compared to the patients with node involvement and in advanced stages.